These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33871096)

  • 1. Aeson-The Carmat total artificial heart is approved for enrollment in the United States.
    Han JJ
    Artif Organs; 2021 May; 45(5):445-446. PubMed ID: 33871096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total artificial heart as a bridge to transplantation.
    Henn MC; Mokadam NA
    Curr Opin Organ Transplant; 2022 Jun; 27(3):222-228. PubMed ID: 35649113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial heart helps people awaiting transplants.
    Meadows M
    FDA Consum; 2005; 39(1):35. PubMed ID: 15803595
    [No Abstract]   [Full Text] [Related]  

  • 4. A space age vision advances in the clinic.
    Marshall E
    Science; 2002 Feb; 295(5557):1000-1. PubMed ID: 11834810
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approval of totally implantable permanent total artificial heart for humanitarian use.
    Nosé Y
    Artif Organs; 2007 Jan; 31(1):1-3. PubMed ID: 17209954
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable total artificial heart developed by Abiomed gets FDA approval for clinical trials.
    Nosé Y
    Artif Organs; 2001 Jun; 25(6):429. PubMed ID: 11453870
    [No Abstract]   [Full Text] [Related]  

  • 7. Totally implanted heart.
    FDA Consum; 2006; 40(6):7. PubMed ID: 17333556
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of artificial heart (assist/replacement) development in the United States.
    Fukamachi K
    Artif Organs; 2013 Aug; 37(8):675-6. PubMed ID: 23944236
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanical devices and US Food and Drug Administration (FDA) approval.
    Reitz BA
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2006; ():123-7. PubMed ID: 16638557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AbioCor totally implantable replacement heart.
    Samuels L
    Am Heart Hosp J; 2003; 1(1):91-6. PubMed ID: 15785182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial heart helps the beat go on. The FDA's approval of an artificial heart paves the way for wider use. But who needs it?
    Harv Heart Lett; 2006 Dec; 17(4):3. PubMed ID: 17290533
    [No Abstract]   [Full Text] [Related]  

  • 12. The CARMAT total artificial heart.
    Mohacsi P; Leprince P
    Eur J Cardiothorac Surg; 2014 Dec; 46(6):933-4. PubMed ID: 25228743
    [No Abstract]   [Full Text] [Related]  

  • 13. All is not well with the artificial heart.
    Kolff WJ
    Artif Organs; 1992 Apr; 16(2):118-22. PubMed ID: 10078232
    [No Abstract]   [Full Text] [Related]  

  • 14. Good news and bad news: the cost of mending a broken heart.
    Williams D
    Med Device Technol; 2003; 14(1):8-10. PubMed ID: 12974118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left-ventricular assist devices as destination therapy for end-stage heart failure.
    TEC Bull (Online); 2002 Nov; 19(3):28-30. PubMed ID: 12839024
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA Advisory Committee favorably votes on OCS Heart.
    Han JJ
    Artif Organs; 2021 Jun; 45(6):544-545. PubMed ID: 34089187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not Your Mother's FDA.
    O'Connor CM
    JACC Heart Fail; 2016 Dec; 4(12):978. PubMed ID: 27908397
    [No Abstract]   [Full Text] [Related]  

  • 18. Left ventricular assist devices in heart failure.
    Kilic A; Ailawadi G
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):649-56. PubMed ID: 22651840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altruism versus reality: an academic medical center's role in device development.
    Copeland JG
    Artif Organs; 2001 Nov; 25(11):862-3. PubMed ID: 11903136
    [No Abstract]   [Full Text] [Related]  

  • 20. Special report: left ventricular assist devices as destination therapy for end-stage heart failure--cost-effectiveness analysis.
    TEC Bull (Online); 2003 Nov; 20(3):33-4. PubMed ID: 15043081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.